Examining Long-Acting Reversible Contraceptive Methods

Similar documents
LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables

Contraception: The Pill Needs to Share (or Move Over) Frankly Speaking EP 17

Can an iud cause back pain

Hereditary Cancer Syndromes and the Obstetrician/Gynecologist

Information for Informed Consent for Insertion of a Mirena IUD

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Postpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

Family Planning UNMET NEED. The Nurse Mildred Radio Talk Shows

Female Sexual Dysfunction: Common Problem But Uncommonly Discussed

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.

Power Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018

Teen Sexual Health Survey

Adolescent Hot Topics: Contraception

WHAT ARE CONTRACEPTIVES?

Can you imagine reversible birth control that s more than 99% effective and 100% hormone free, too?

The use of long-acting reversible contraceptive

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)

LARC. sample. ask brook about. Are any of them right for me? How effective is it? How long does it last? long acting reversible contraception

Instruction for the patient

Example CLINICAL GUIDELINES for Postpartum IUD insertion

What s New in Adolescent Contraception?

Essure By Mayo Clinic staff

The HPV Vaccine: Not Just for Young Girls and Teens

Fitting of an Intrauterine Device (IUD)

the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to

PREVENTING PREGNANCY: TALKING ABOUT AND USING CONTRACEPTION

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40

Contraceptives. Kim Dawson October 2010

Discover the birth control you ve been looking for. Highly reliable. Virtually hassle-free. Totally hormone-free.

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine

Helping Cancer Patients with Quality of Life Issues Post Hysterectomy

The Diabetes Breakthrough: Dr. Osama Hamdy on his 12-week Plan

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that

Effective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

100% Highly effective No cost No side effects

Ginkgo Biloba: How Supportive is the Data?

Expert Tips for Diagnosis and Management of Bacterial Vaginosis

FACT SHEET: Copper IUD

Carotid Ultrasound Scans for Assessing Cardiovascular Risk

Beyond The Data: Promoting Well-being in Older Adults

Ultra-Portable Ultrasound in the Critical Care Unit

Aspirin Resistance and Its Implications in Clinical Practice

Statin Intolerance: Keys to Patient Counseling and Guidance

Dedicated postpartum IUD inserter. Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016

International Federation of Gynecology and Obstetrics

Herpes Zoster Vaccination: New Recommendations for Shingles Prevention - Frankly Speaking EP 50

Before beginning this activity, be sure to review the faculty and commercial support disclosures, as well as the Learning Objectives.

Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN

Medical Eligibility for Contraception Use

PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE

Same-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After

Endometriosis. *Chocolate cyst in the ovary

Biomarkers for Underreported Alcohol Use

TRANSCRIPT. Do Corticosteroids Decrease the Pain of Acute Pharyngitis? - Frankly Speaking EP 18

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH

ANALYZING CONTRACEPTION OPTIONS

Birth Control Options Chart

Communication Methods for Proper Engagement in a Discussion about Overactive Bladder and Recommended Treatment Options

Deciphering Chronic Pain and Pain Medicine

Nontuberculous Mycobacteria (NTM) in Patients with Cystic Fibrosis

Mycoplasma Genitalium: Get to Know the Hidden STI

Comparing Liquid-Based Cytology Methods in the Detection of Cervical Cancer: Perspectives from Dr. Daniel Ferrante

Intrauterine Contraception: A First-tier Choice Throughout the Female Reproductive Life Cycle

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital

LARC IN THE OFFICE BASE SETTING. Regina Lewis, DO Associate Professor of Family Medicine OSU Family Medicine

Combining Individualized Treatment Options with Patient-Clinician Dialogue

Sudden Cardiac Death Prevention: ICD Indications

VCHIP LARC Needs Assessment Survey

Section 4 Decision-making

Ultrasound: Improving Breast Cancer Detection

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.

Smoking Cessation Strategies for the 21st Century

Product Information. Confidence that lasts

Normalizing STI Screening: The Patient Impact

17. Preventing pregnancy

Birth Control. Choosing the method that s right for you

Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer

The number of women using long-acting reversible

Hypoactive Sexual Desire Disorder: Advances in Diagnosis and Treatment

CONFERENCE SCHEDULE. Demonstrate correct hand skills necessary for placement of the copper IUD and each of the three levonorgestrel IUDs.

Type 1 Diabetes: Control and Cure

Levosert levonorgestrel 20mcg/24hour intrauterine device

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

Final Report: Qualitative Interviews with Mirena Users and their Partners in Kenya

A Lesson Plan from Rights, Respect, Responsibility: A K-12 Curriculum

Tracking Genetic-Based Treatment Options for Inflammatory Bowel Disease

Percentage of family planning clinics, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and 2015

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

BBC LEARNING ENGLISH 6 Minute English Cigarettes v e-cigarettes

Sexual Function and Fertility in Men After Cancer

Contraceptive case studies. Dr Christine Roke National Medical Advisor Family Planning June 2015

Breast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Introduction

Adnexal Mass Management: Risk Stratification and Management Practice for Best Patient Outcomes

Transcription:

Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/examining-long-acting-reversible-contraceptivemethods/7078/ ReachMD www.reachmd.com info@reachmd.com (866) 423-7849 Examining Long-Acting Reversible Contraceptive Methods Hello. This is Dr. Prathima Setty and I'm your host for this segment on Reach MD. Today we are speaking with Dr. Eve Espey. Dr. Espey is the Chairperson of the Department of OB-GYN, Professor in the Division of Family Planning and Fellowship Director for the Family Planning Program at the University of New Mexico. She is also President Elect of the Society of Family Planning and is the Medical Advisory Committee Chair for the National Campaign to Prevent Teen and Unplanned Pregnancy. She has won numerous teaching awards and has also received the prestigious Rashbaum Award for recognition of her impact on training and service in abortion provision. She has numerous publications and has presented nationally on the topics of contraception and abortion. Dr. Espey, thank you so much for joining us here today. Thank you. In the recent, there has been a real focus and attempt to use more long-acting reversible contraceptive methods in clinical practice, can you comment on why you think is so? 2018 ReachMD Page 1 of 9

The increase in interest in long-acting reversible contraceptives really goes along with their tremendous effectiveness and their great side effect profile. It's increasingly been recognized that the majority of women are good candidates for both of the long-acting methods, both the intrauterine device, the IUD, as well as the contraceptive implant. In the past there were concerns about who good candidates were for these methods, and these days a very large body of evidence points to the safety and effectiveness of these methods. So, they really have the opportunity to reduce the very high rate of unintended pregnancies that we see in this country. And have you found that these long-acting reversible contraceptive methods, are they more effective than birth controls pills and the patch, NuvaRing, those other types of methods that we generally have used in the past? Yes. So, we consider the long-acting methods to be the IUD and the contraceptive implant, and the short-acting methods are the ones that you talked about which are the birth control pill, the patch and the ring and to some extent Depo-Provera. Depo-Provera is the shot that you get every three months and even though that's a longer-acting method, it still requires multiple acts of motivation to continue the method. So, what's been found, particularly in a recent research project called the Contraceptive Choice Project, is that the long-acting methods, the IUD and the implant, are about 20 times more effective in preventing unintended pregnancy than the short-acting methods. So, that's why there's such a focus on these methods because they work so much better. So, as far as counseling a patient in the office with the different options of IUD, Mirena versus ParaGard and for that matter, the Nexplanon or Implanon, how do you approach this? How do you present these options? So, it's always very important to present contraceptive options to women in a way that they have the choice of options, so there are a number of different choices including the short-acting methods as well as the long-acting methods. However, just the way we would present options for other medical conditions, for example hypertension, we would talk about the most effective methods first, that's the way I approach talking to women about contraceptive methods in terms of the long-acting methods. So, again, very important for women to make their own choice, but I do tend to open the conversation about contraceptive options talking about the IUD and the implant. 2018 ReachMD Page 2 of 9

Now, in terms of those options, the copper IUD is a ten-year option. It's very good for women who desire a non-hormonal method or who want contraception for greater than a year. There is sometimes increased bleeding or cramping with periods with the copper IUD. The hormone IUD lasts for five years. It most often reduces menstrual bleeding and for some women there is no bleeding at all. That's a great option again for women who desire contraception for a longer term period, more than six months to a year. And again, both of these methods are what we call forgettable meaning once they're initiated there's no ongoing maintenance that's needed. In terms of the Nexplanon, that's the contraceptive implant. Again, good for women who desire longer term contraception for more than six months to a year. There are some leading irregularities with the Nexplanon that may be well accepted by some women, but not as well accepted by others. So, are there any absolute contraindications for the IUD? So, absolute contraindications are few and far between. They include an active pelvic infection within the past three months. They include a uterine cavity that is unable to accept an IUD, so if there is an abnormality of the cavity of the uterus, there are some uterine abnormalities that cause the shape of the uterus to be such that an IUD can't be placed, so that's an absolute contraindication. Obviously, pregnancy is an absolute contraindication to the IUD. So, do you do an ultrasound prior to insertion for these women to check and see if they have uterine abnormalities or do you generally don't do that? We generally don't do that. Uterine abnormalities are pretty unusual and many uterine abnormalities, for example, we think of the uterus as triangular in shape in terms of the cavity, uterine abnormalities may be where one side of the uterus is much bigger than the other. Many common uterine abnormalities are such that an IUD can be placed. And still be effective, is that... And it's still effective, yes. Ultrasound prior to IUD placement is rarely needed unless there is an abnormality that's suspected. 2018 ReachMD Page 3 of 9

So, what do you quote as the risk of pregnancy with a properly-placed IUD versus Nexplanon, I'm assuming very, very low. Both are very low. The pregnancy rate with the IUD, both the copper and the hormone, we quote at about one percent or slightly less whereas with the Nexplanon it's actually much less than one percent. So, looking at the two methods side by side, Nexplanon is far more effective even than the IUD, but IUDs are so highly effective that we do consider them all in the same group. So, what do you quote as the amenorrhea rate after Mirena versus Nexplanon, are they similar? The Mirena has a higher rate of amenorrhea than Nexplanon and it's more predictable. About 20 percent of women after a year have amenorrhea with the Mirena and that percentage increases over time whereas one of the difficulties in counseling women about the Nexplanon is that the bleeding pattern is often unpredictable. So, a woman may have a period of amenorrhea, but may then have several months of irregular bleeding. So, although amenorrhea does occur with about 20 percent of women with the implant, it's difficult to predict who those women will be and whether that pattern will sustain over time. So, how do you manage those bleeding abnormalities after IUD placement? Oftentimes you hear women who have a lot of bleeding after these IUD placements, what is considered acceptable and how do you manage that? The major complaint with the copper IUD is heavy bleeding with cramping. The main complaint with the hormone IUD is irregular bleeding or no bleeding, so it's very important upfront to counsel women that they may have very little or no bleeding with the hormone IUD. With the Nexplanon it's irregular, unpredictable bleeding. So, for example with the hormone IUD and the copper IUD, the rates of discontinuation due to bleeding are similar. It's about ten percent in the first year, but the reasons for discontinuation are different, one is too much bleeding, the other is irregular bleeding. Similarly with the contraceptive implant, irregular bleeding leads the list of reasons why women stop using the implant. What would be considered acceptable time for the patient as far as their bleeding issues, a few 2018 ReachMD Page 4 of 9

months? And do you give them any medication to help with the bleeding at that time? So, for the copper IUD we often recommend using nonsteroidal anti-inflammatories. Use of Ibuprofen, for example, not only reduces cramping with the IUD, but it also reduces the volume of bleeding, so that's a commonly prescribed medication in women who use the copper IUD. For the hormone IUD we usually counsel that irregular bleeding is most likely time-limited within about three months. We will counsel that the woman may experience irregular bleeding for up to three months. After three months the most common pattern is either oligo-amenorrhea or complete amenorrhea. When women come in...let's say a woman comes in at six months still complaining of irregular bleeding with the hormone IUD, I will sometimes, if she is an appropriate candidate, recommend one to three months of oral contraceptives to see if that makes an impact. There's not a huge amount of data for that, but it may help with the bleeding pattern and allow a woman to continue an IUD that she would otherwise discontinue. I do a similar approach with women using the contraceptive implant. If the most common reason that women want the implant removed is because of daily spotting or daily heavier bleeding, sometimes giving a short trial of oral contraceptives on top of the implant will help alleviate the problem. And do you generally use a 20 microgram combination pill or do you go higher than that? What is your general practice? I usually use a 30 or 35 microgram pill most commonly because it's cheaper. The Sprintec, which is a generic of a 35 microgram pill, is available at certain pharmacies for $9 a month whereas other oral contraceptives are significantly more expensive. But also, the 30 or 35 microgram pills tend to do a slightly better job with really alleviating the bleeding irregularity that tends to be frustrating the patient very much at that time. So, do you ever do an endometrial biopsy with the IUD in place in those patients who have continued abnormal bleeding or is that generally not a practice that you do? No. So, two situations, one is in a woman with a hormone IUD irregular bleeding is expected. Also, we know that the hormone IUD has a great reduction in risk of uterine cancer as one of its noncontraceptive benefits, so the likelihood of an endometrial cancer in a young woman using a hormone 2018 ReachMD Page 5 of 9

IUD is extremely low. Now, conversely in a woman with a copper IUD who develops unscheduled bleeding who's over 35, we will typically do an endometrial biopsy, but leave the IUD in place. There's no reason to remove the IUD just to do an endometrial biopsy. So, in that situation does the IUD get in the way of doing the biopsy because it's in the uterine cavity? Yeah. But as it turns out it does not disrupt the IUD, and the IUD does not interrupt the ability to perform the biopsy. What are some tips that you give providers to avoid perforation of the uterus, that's always something all providers are worried about doing at the time of insertion. What is some guidance that you can give those clinicians? I think the most important tip for preventing perforation is to use the same technique described in the package insert for IUD insertion, particularly when a provider is new at performing IUD insertions. So, for example, I'm in a teaching institution, so I'm always teaching somebody to place an IUD, so I follow the package insert directions very closely. So, for example, I always place a tenaculum, I always sound the uterus, and then use the appropriate technique again as described in the package insert. Now, for providers who are very experienced with IUD insertion, removing the step of using the tenaculum or of sounding the uterus may be practiced, but I think particularly during that learning curve with difficult IUD insertions, really following the same standardized technique with every IUD insertion can be quite helpful. And what about those patients with a severely retroverted or severely anteverted uterus, do you ever have difficulty placing the IUDs in those situations, or can you offer any advice on those types of patients? In the setting of a difficult IUD insertion and when my manual exam has demonstrated that the uterus is severely anteverted or retroverted, occasionally ultrasound guidance may be helpful. Most of the time with careful technique, ultrasound guidance is not needed, but I think with any difficult IUD insertion there are other factors that may help making sure that the patient is comfortable. So, for example, either giving PO narcotics or considering a paracervical block, using other instruments, an Os finder or 2018 ReachMD Page 6 of 9

dilators, having those kinds of instruments on hand for the difficult IUD insertion can be quite helpful. So, do you generally remove an IUD and place another one in the same day or do you have them come back? Absolutely, same day. I think we really need to change the way we approach contraception in general, that it's an emergency, so anything that we can do the same day we should do the same day. We have a same-day insertion protocol for placing IUDs, so if a woman comes in and we can reasonably rule out pregnancy, we will place the IUD on the same day. And as far as ruling out pregnancy, do you check a pregnancy test on all your patients before insertion or what's your general protocol with that? We do a pregnancy test on all women unless, for example, they have an IUD in place at the time that they come in or another long-acting method. We follow the United States Specific Practice Recommendations for how to reasonably rule out that a woman is pregnancy. So, we ask about whether she's had unprotected sex within the last week or two prior to her presentation as well as doing the pregnancy test. So, in the office I've often heard of patients complaining of mood changes, weight gain and other progesterone type of effects after Mirena placement, do you think this is common and how do you manage that? Hormone-related side effects, we definitely hear those complaints with both the Mirena IUD and with the Nexplanon. The amount of hormone released by the hormone IUD is very small, so many of those complaints are unlikely related to the hormone. For example, weight gain, studies have not documented weight gain with the hormone IUD, but in general if patients believe that they have side effects that are caused by hormones it can be difficult to change their minds or their attitudes about that. So, in general I am guided by what patients want. Oftentimes reassurance is helpful. For example, weight gain, reassuring patients that studies don't show evidence of weight gain either with the contraceptive implant or with the hormone IUD, that can be helpful, talking about diet and exercise, for example, but sometimes people feel very strongly that their side effects are related to hormones and 2018 ReachMD Page 7 of 9

then another conversation is necessary. So, in those instances do you sometimes have to take the Mirena out? Yes. And again, I think that gets back to women should have a free choice of contraceptive methods and initiating and ending them whenever they want. Somebody may come in and say they have a side effect that they are sure is related to the device that I may not think is related to the device, but ultimately the patient is in charge and it's very important to honor their wishes. Another question for you, Dr. Espey, how do you manage someone who comes in for an IUD check and you look inside the vagina with a speculum and you don't see the IUD string, how would you manage that? The first test to do when there is no IUD string is an ultrasound. We're fortunate in our office, we have both transabdominal and transvaginal ultrasound and most frequently performing an ultrasound will confirm the presence of the IUD. The copper IUD is much easier to see on ultrasound than the hormone IUD. Occasionally it's very easy to see the hormone IUD, but sometimes it's more subtle, but most of the time we can verify the presence with ultrasound. If the ultrasound does not show an IUD in the uterus then the next step is to do an X-ray of the abdomen and it's very important in that X-ray to visualize the entire abdomen and pelvis in order to locate a potentially perforated IUD that's wound up in the intraabdominal location. So, in the instance that you need to take the IUD out and you can't see the string, what are some tips that you can give clinicians with that experience? So, if the IUD is in the uterus, but there are no visible strings there are two instruments that are very helpful in removing the IUD. The traditional instrument is called an IUD hook. It's a metal instrument that has a pronounced hook at the end, but actually a much better instrument is the IUD removal forceps. There is one in particular that's spelled, it's a French name, Mathieu, M-A-T-H-I-E-U, IUD removal forceps. It's a small alligator forceps that is so small it's very easy to sneak it up both into the endocervical canal as well as into the uterus in order to grab either the body of the IUD or the string, and I think anybody who practices contraception should have one of these alligator IUD removal 2018 ReachMD Page 8 of 9

forceps. And in your experience have you ever seen an IUD imbedded in the uterus preventing removal? There have been IUDs that are either imbedded or are configured in such a way in the uterus that they're difficult to remove, and occasionally those patients we take to surgery for an operative hysteroscopy where we place an endoscope into the uterus in order to facilitate the removal. So, can you discuss placement of IUDs after delivery? What is your expulsion rate and do patients get frustrated if they pay for an IUD and then it comes out? What's your experience with that? We do quite a bit of immediate postpartum IUD placement in our hospital. We're fortunate to live in a state where Medicaid covers immediate postpartum IUD insertion as well as implant placement prior to hospital discharge after a delivery. So, we've developed a transcesarean technique where we place the IUD right after the baby and the placenta have been removed after a C-section and a ring forceps technique for placing the IUD in the uterus right after a vaginal delivery. The expulsion rate is variable. In the literature the expulsion rate varies from about ten percent to about 30 percent, so it's very difficult with the existing data to know exactly where that expulsion rate is. It also appears to decline with experience, so the more experience a provider has, the lower the expulsion rate likely is with postpartum IUD insertion. Well, thank you very much, Dr. Espey, for being with us today and for sharing with us your thoughts on this important topic. Oh, no problem at all. Thank you for doing it. I'm your host, Dr. Prathima Setty, and you've been listing to Reach MD. If you missed any part of this discussion, please visit ReachMD.com to download this broadcast. Thank you for listening. 2018 ReachMD Page 9 of 9